Morgan Feely

2.2k total citations · 1 hit paper
18 papers, 1.7k citations indexed

About

Morgan Feely is a scholar working on Psychiatry and Mental health, Pediatrics, Perinatology and Child Health and Cellular and Molecular Neuroscience. According to data from OpenAlex, Morgan Feely has authored 18 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Psychiatry and Mental health, 8 papers in Pediatrics, Perinatology and Child Health and 6 papers in Cellular and Molecular Neuroscience. Recurrent topics in Morgan Feely's work include Epilepsy research and treatment (8 papers), Pharmacological Effects and Toxicity Studies (7 papers) and Neuroscience and Neuropharmacology Research (6 papers). Morgan Feely is often cited by papers focused on Epilepsy research and treatment (8 papers), Pharmacological Effects and Toxicity Studies (7 papers) and Neuroscience and Neuropharmacology Research (6 papers). Morgan Feely collaborates with scholars based in United Kingdom, United States and Ireland. Morgan Feely's co-authors include Jeremy R.M. Haigh, Robert J. Unwin, David V. Milford, Zvi Farfel, Graham Lipkin, Carol Nelson‐Williams, Jean‐Michel Achard, Sandra Disse-Nicodème, Frederick H. Wilson and Kazuhiko Ishikawa and has published in prestigious journals such as Science, The Lancet and The American Journal of Cardiology.

In The Last Decade

Morgan Feely

17 papers receiving 1.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Human Hypertension Caused by Mutations in WNK Kinases

2001 1.1k citations Frederick H. Wilson, Sandra Disse-Nicodème et al. Science profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Morgan Feely United Kingdom	13	975	342	270	247	217	18	1.7k
Roland Veelken Germany	33	512 0.5×	622 1.8×	355 1.3×	272 1.1×	205 0.9×	126	3.0k
Jean‐Louis Imbs France	24	263 0.3×	289 0.8×	57 0.2×	165 0.7×	112 0.5×	80	1.4k
Mara Ferrandi Italy	26	1.5k 1.5×	824 2.4×	379 1.4×	261 1.1×	105 0.5×	77	2.4k
Alfonso M. Lechuga‐Sancho Spain	21	384 0.4×	237 0.7×	175 0.6×	124 0.5×	132 0.6×	85	1.6k
Satish A. Eraly United States	26	608 0.6×	67 0.2×	133 0.5×	75 0.3×	82 0.4×	43	2.2k
Wen‐Liang Song United States	24	325 0.3×	187 0.5×	177 0.7×	106 0.4×	69 0.3×	37	1.9k
Jorge Gamboa United States	25	805 0.8×	170 0.5×	98 0.4×	150 0.6×	84 0.4×	66	2.2k
Antonio Siniscalchi Italy	25	592 0.6×	78 0.2×	48 0.2×	96 0.4×	755 3.5×	103	2.1k
Tim West United States	25	501 0.5×	321 0.9×	202 0.7×	111 0.4×	256 1.2×	63	2.4k
Linda N. Peterson Canada	17	524 0.5×	61 0.2×	69 0.3×	210 0.9×	163 0.8×	35	881

Countries citing papers authored by Morgan Feely

Since Specialization

Citations

This map shows the geographic impact of Morgan Feely's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Morgan Feely with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Morgan Feely more than expected).

Fields of papers citing papers by Morgan Feely

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Morgan Feely. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Morgan Feely. The network helps show where Morgan Feely may publish in the future.

Co-authorship network of co-authors of Morgan Feely

This figure shows the co-authorship network connecting the top 25 collaborators of Morgan Feely. A scholar is included among the top collaborators of Morgan Feely based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Morgan Feely. Morgan Feely is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Feely, Morgan, et al.. (2009). THE EFFECT OF ANTICONVULSANT DRUGS WHICH INDUCE LIVER MICROSOMAL ENZYMES ON DERIVED AND INGESTED PHENOBARBITONE LEVELS. Acta Neurologica Scandinavica. 56(1). 1–6. 1 indexed citations

Kemp, Steven, et al.. (2006). Psychological factors and use of antiepileptic drugs: Pilot work using an objective measure of adherence. Psychology Health & Medicine. 12(1). 107–113. 20 indexed citations

Sano, Mary, et al.. (2005). Undertreatment of patients with Alzheimer's disease in an elderly United States population. Alzheimer s & Dementia. 1(2). 136–144. 23 indexed citations

Collins, Rónán & Morgan Feely. (2002). Practical diagnosis and management of seizures.. PubMed. 246(1632). 188–94. 3 indexed citations

Wilson, Frederick H., Sandra Disse-Nicodème, Keith A. Choate, et al.. (2001). Human Hypertension Caused by Mutations in WNK Kinases. Science. 293(5532). 1107–1112. 1114 indexed citations breakdown →

Feely, Morgan, et al.. (1998). Once a Day is Best: Evidence or Assumption?. Drugs & Aging. 13(3). 223–227. 12 indexed citations

Roberts, Sarah J., et al.. (1998). Prescribing of anti-epileptic drugs in the northern and Yorkshire region: 1992–1995. Seizure. 7(2). 127–132. 13 indexed citations

Feely, Morgan, et al.. (1997). Steady-state clearance rates of warfarin and its enantiomers in therapeutically dosed patients. Chirality. 9(1). 13–16. 10 indexed citations

Wolff, Kim, et al.. (1993). Use of ‘very low-dose phenobarbital’ to investigate compliance in patients on reducing doses of methadone (detoxification). Journal of Substance Abuse Treatment. 10(5). 453–458. 4 indexed citations

10.

Beevers, DG, et al.. (1991). Comparison of lisinopril versus atenolol for mild to moderate essential hypertension. The American Journal of Cardiology. 67(1). 59–62. 10 indexed citations

11.

Wolff, Kim, Alastair Hay, Duncan Raistrick, Robert Calvert, & Morgan Feely. (1991). Measuring compliance in methadone maintenance patients: Use of a pharmacologic indicator to “estimate” methadone plasma levels. Clinical Pharmacology & Therapeutics. 50(2). 199–207. 24 indexed citations

12.

Feely, Morgan, et al.. (1989). Lack of anticonvulsant tolerance with RU 32698 and Ro 17-1812. European Journal of Pharmacology. 164(2). 377–380. 29 indexed citations

13.

Pullar, T, et al.. (1989). Time to stop counting the tablets?. Clinical Pharmacology & Therapeutics. 46(2). 163–168. 188 indexed citations

14.

Haigh, Jeremy R.M. & Morgan Feely. (1988). RO 16-6028,a benzodiazepine receptor partial agonist, does not exhibit anticonvulasant tolerance in mice. European Journal of Pharmacology. 147(2). 283–285. 35 indexed citations

15.

Gent, J P, et al.. (1988). Can benzodiazepines be classified by characterising their anticonvulsant tolerance-inducing potential?. European Journal of Pharmacology. 145(1). 75–80. 30 indexed citations

16.

Haigh, Jeremy R.M. & Morgan Feely. (1988). Tolerance to the anticonvulsant effect of benzodiazepines. Trends in Pharmacological Sciences. 9(10). 361–366. 83 indexed citations

17.

Gent, J P, Mark Bentley, Morgan Feely, & Jeremy R.M. Haigh. (1986). Benzodiazepine cross-tolerance in mice extends to sodium valproate. European Journal of Pharmacology. 128(1-2). 9–15. 25 indexed citations

18.

Feely, Morgan, Robert Calvert, & John S. Gibson. (1982). CLOBAZAM IN CATAMENIAL EPILEPSY. The Lancet. 320(8289). 71–73. 64 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact